Preoperative Block for Anterior Cervical Spine Surgery
ESPB/ICPB
Preoperative Ultrasound-Guided Intermediate Cervical Plexus Block Versus Preoperative Cervical Erector Spinae Plane Block for Anterior Cervical Spine Surgery: A Randomized Controlled Study
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of this clinical trial study is to compare the analgesic effects of ultrasound-guided intermediate cervical plexus block Versus cervical erector spinae block in patients undergoing anterior cervical spine surgery.
- The main questions it aims to answer are:
- The primary outcome will be recording postoperative pain intensity using Numerical Rating Scale (NRS).
- The secondary outcomes will be measuring the performance time, onset of the sensory block, intraoperative fentanyl consumption, time to the first call for rescue analgesia (nalbuphine), postoperative total nalbuphine consumption, and postoperative complications such as nausea, vomiting, hypotension, and bradycardia.
- We will compare two blocks to a placebo.
- Participants will:
- undergo ultrasound-guided intermediate cervical plexus block or cervical erector spinae block or a placebo
- Be assessed for pain after 2 h, 4 h, 6 h, 12 h, and 24 h postoperatively
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2025
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedMarch 10, 2025
March 1, 2025
1 year
February 21, 2025
March 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in postoperative pain intensity using Numerical Rating Scale
Numeric Rating Scale ( NRS) score, a commonly used 11-point numeric scale ranges from '0' representing one pain extreme (no pain) to '10' representing the other pain extreme ( pain as bad as you can imagine or worst pain imaginable). The patient will be instructed to mark along the line to represent the intensity of pain currently being experienced.
(Day 1) 30 minutes, 2 hours, 4 hours, 6 hours, 12 hours, and 24 hours postoperative
Secondary Outcomes (3)
Change in the time of performance of the technique in minutes.
Perioperative/Periprocedural
Change in the time to the first call for analgesia (nalbuphine) in hours.
Perioperative/Periprocedural
The total measure of nalbuphine given to each patient during the first 24 hours of the postoperative period
Perioperative/Periprocedural
Study Arms (3)
Intermediate cervical plexus block
ACTIVE COMPARATORThe patient will be positioned supine with a slight elevation of the head and the head turned away from the blocked side. After sterilizing the skin, the ultrasound probe will be placed over the middle of the posterior border of the sternocleidomastoid muscle. The needle will be inserted in-plane while keeping the probe in a transverse position. The needle tip will be placed under the sternocleidomastoid muscle and below the superficial fascia, and then, a total volume of 15 ml of 0.25% bupivacaine will be injected bilaterally. The spread of the local anesthetic will be visualized using ultrasound guidance. The same steps will be repeated on the other side.
Cervical Erector spinae block
ACTIVE COMPARATORThe patient will be positioned laterally, with a pillow under their head. Transverse ultrasound scanning of the lower cervical area will be done. Starting from the supraclavicular brachial plexus, the transducer will be slid in a cephalic direction to show the transverse process of the C7 vertebra. Then, it will be moved further cephalic to display the transverse process of C6, along with its characteristic anterior and posterior tubercles. The transducer will be then slid posteriorly to show the posterior tubercle of C6, along with the posterior neck muscles above it (trapezius, levator scapula, and erector spinae). After prepping and draping the patient using aseptic technique, the needle will be inserted (in plane technique from posterior) until it will reach the posterior tubercle of C6. Then, a total volume of 15 ml of bupivacaine 0.25% will be injected bilaterally. The same steps will be repeated on the opposite side.
Control group
PLACEBO COMPARATORTotal volume of 15 ml of saline 0.9% will be injected subcutaneous bilaterally
Interventions
The patient will be positioned supine with a slight elevation of the head and the head turned away from the blocked side. After sterilizing the skin, the ultrasound probe will be placed over the middle of the posterior border of the sternocleidomastoid muscle. The needle will be inserted in-plane while keeping the probe in a transverse position. The needle tip will be placed under the sternocleidomastoid muscle and below the superficial fascia, and then, a total volume of 15 ml of 0.25% bupivacaine will be injected bilaterally. The spread of the local anesthetic will be visualized using ultrasound guidance. The same steps will be repeated on the other side
Total volume of 15 ml of saline 0.9% will be injected subcutaneous bilaterally
Eligibility Criteria
You may qualify if:
- Both sex
- Age: between 21 and 60 years
- Physical status: belongs to American Society of Anesthesiologists (ASA) I, II
- Body mass index (BMI): from 25 to 30 kg/m2
- Type of surgery: elective anterior cervical spine surgery under general anesthesia
You may not qualify if:
- Refusal of participation.
- local infection at the puncture site.
- Mental or physical disability.
- History of allergy to study drugs (bupivacaine, fentanyl).
- Hematological disorders including coagulation abnormalities.
- Severe hepatic or kidney impairment.
- Chronic pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University Teaching Hospital
Tanta, Qism Awwal Tanta, 31111, Egypt
Related Publications (2)
Kamel AAF, Fahmy AM, Fathi HM, Elmesallamy WAEA, Khalifa OYA. Regional analgesia using ultrasound-guided intermediate cervical plexus block versus cervical erector spinae block for anterior cervical spine surgery: a randomized trial. BMC Anesthesiol. 2024 Apr 22;24(1):153. doi: 10.1186/s12871-024-02533-6.
PMID: 38649826RESULTAbdelhaleem NF, Youssef EM, Hegab AS. Analgesic efficacy of inter-semispinal fascial plane block in Patients undergoing Cervical Spine Surgery through Posterior Approach: a randomized controlled trial. Anaesth Crit Care Pain Med. 2023 Aug;42(4):101213. doi: 10.1016/j.accpm.2023.101213. Epub 2023 Mar 7.
PMID: 36894055RESULT
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
February 21, 2025
First Posted
March 10, 2025
Study Start
April 1, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
March 10, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share